ストックスクリーナーアプリを入手
3.8664
2.34%
-0.0936
前日終値:
$3.96
開ける：
$3.5
24時間の取引高:
88,754
Relative Volume:
0.85
時価総額：
$24.26M
収益：
-
当期純損益:
$-4.69M
株価収益率:
-1.6594
EPS:
-2.33
ネットキャッシュフロー:
$-3.81M
1週間 パフォーマンス:
-7.92%
1か月 パフォーマンス:
-10.89%
6か月 パフォーマンス:
+364.43%
1年 パフォーマンス:
+102.48%
1日の値動き範囲:
$3.50
$3.9399
1週間の範囲:
$3.50
$4.31
52週間の値動き範囲:
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
名前
Lixte Biotechnology Holdings Inc
セクター
電話
310 203 2902
住所
433 PLAZA REAL, BOCA RATON
LIXT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.8694 | 24.83M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.75 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.54 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.61 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.42 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.74 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lixte Biotechnology Holdings Inc (LIXT) 最新ニュース
Lixte Biotechnology raises $4.3 million in registered direct offering - Investing.com
Lixte Biotechnology raises $4.3M in market-priced registered direct offering - marketscreener.com
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - The Manila Times
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million - GlobeNewswire
Will Lixte Biotechnology Holdings Inc. stock split again soon2025 Short Interest & Stepwise Entry and Exit Trade Signals - Улправда
Lixte Biotechnology shareholders approve board nominees and stock plan amendment - Investing.com
Lixte Biotechnology shareholders approve board nominees and stock plan amendment By Investing.com - Investing.com South Africa
Lixte Biotechnology Holds Annual Meeting, Approves Key Issues - TipRanks
Lixte’s Big Bet: Making Other Cancer Drugs Work Harder - InvestorNews
LIXTE (NASDAQ: LIXT) expands oncology platform with LiGHT proton therapy system - Stock Titan
Lixte Biotechnology (LIXT) Stock Analysis Report | Financials & Insights - Benzinga
Meme Stocks: Will Lixte Biotechnology Holdings Inc stock maintain momentum in 2025Quarterly Trade Report & Free Weekly Watchlist of Top Performers - moha.gov.vn
Lixte Biotechnology shares slide following purchase of UK-based Liora - MSN
Is Lixte Biotechnology Holdings Inc. (8640) stock a buy on weaknessWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Will Lixte Biotechnology Holdings Inc. stock maintain momentum in 2025Market Trend Summary & Daily Oversold Stock Bounce Ideas - Newser
What sentiment indicators say about Lixte Biotechnology Holdings Inc. stockJuly 2025 EndofMonth & Fast Momentum Entry Tips - Newser
Is Lixte Biotechnology Holdings Inc. (8640) stock undervalued historicallyQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser
Can Lixte Biotechnology Holdings Inc. stock deliver consistent earnings growthJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Published on: 2025-12-04 00:03:12 - Newser
LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology - Yahoo Finance
LIXTE (NASDAQ: LIXT) advances LB-100 combos with GSK, Roche and refines long-term strategy - Stock Titan
Will Lixte Biotechnology Holdings Inc. (8640) stock rise with strong economy2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
There is no doubt that Lixte Biotechnology Holdings Inc (LIXT) ticks all the boxes. - Setenews
Lixte Biotechnology Acquires Liora Technologies for Growth - TipRanks
LIXTE Biotechnology acquires UK-based proton therapy developer Liora By Investing.com - Investing.com Nigeria
Lixte Biotechnology stock falls after acquiring UK-based Liora By Investing.com - Investing.com
Lixte Biotechnology stock falls after acquiring UK-based Liora - Investing.com
LIXTE Biotechnology (LIXT) Expands with Acquisition of Liora Tec - GuruFocus
LIXTE Biotechnology acquires UK-based proton therapy developer Liora - Investing.com India
LIXTE Biotechnology Holdings, Inc. Completes Acquisition of Liora Technologies Europe Ltd. to Advance Proton Therapy Treatment for Cancer - Quiver Quantitative
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment - InvestorNews
S&P 500, Dow and NASDAQ end day on positive note as Wall Street begins Thanksgiving week on high with boos - The Economic Times
Lixte Biotechnology announces $5M equity financing; shares down - MSN
Will Upside Catalysts Materialize for Vallabh Steels Limited in YEARGrowth Stock Opportunities & Small Capital Investment Tips - earlytimes.in
Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants By Investing.com - Investing.com Australia
Earlyworks shareholders reject share issuance for acquisition, approve new directors and warrants - Investing.com UK
Lixte Biotechnology Holdings Inc. (LIXT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Key Metrics Every Investor Should Know About Shree Hari Chemicals Export Limited - earlytimes.in
Will Lixte Biotechnology Holdings Inc. Equity Warrant stock benefit from automation - newser.com
Can Lixte Biotechnology Holdings Inc. stock maintain growth trajectory2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock positioned well for digital economy2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Can Lixte Biotechnology Holdings Inc. Equity Warrant stock sustain market leadership2025 Top Gainers & Free Weekly Watchlist of Top Performers - newser.com
Will Lixte Biotechnology Holdings Inc. stock attract ESG investorsTake Profit & Growth Focused Stock Pick Reports - newser.com
Will Lixte Biotechnology Holdings Inc. (8640) stock hit analyst forecasts2025 Macro Impact & Safe Entry Momentum Stock Tips - newser.com
Is Lixte Biotechnology Holdings Inc. stock a safe buy before earnings2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Is Lixte Biotechnology Holdings Inc. (8640) stock a buy during volatile marketsJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
Is Lixte Biotechnology Holdings Inc. stock resilient to inflation2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
Lixte Biotechnology Holdings Inc (LIXT) 財務データ
収益
当期純利益
現金流量
EPS
0.92%
0.10%
大文字化:
|
ボリューム (24 時間):